Late-stage applicants being snapped up by the majors...with another (privately-held) one being purchased yesterday (Aurora bought H2 Biopharma). With PUF being in the same state at H2 and being publicly traded, I think it looks ripe for a takeover as well. The larger producers want the greenhouse space and the production quota, so they are taking over smaller late-stage applicants to build up their stable of producing assets.
Who will be taken over next? Along with PUF, I also purchased VP and MMJ (who is tied to THREE separate late-stage applicants)...
BB